ZOFRAN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, Nigeria, Poland, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug ZOFRAN contains one active pharmaceutical ingredient (API):

1	Ondansetron UNII NMH84OZK2B - ONDANSETRON HYDROCHLORIDE
	Ondansetron is a potent, highly selective 5HT3 receptor-antagonist. Its precise mode of action in the control of nausea and vomiting is not known.
	Read more about Ondansetron

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZOFRAN Suppositories	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A04AA01	Ondansetron	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists
Discover more medicines within A04AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1594X, 1595Y, 5848T, 5967C, 5968D, 5969E, 5970F, 8224W, 8225X, 8233H, 8410P, 8411Q, 8412R, 8413T, 9441X
BR	Câmara de Regulação do Mercado de Medicamentos	526517080091217, 526517080091317
CA	Health Products and Food Branch	02213567, 02213575, 02213745, 02229639, 02239372, 02239373
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00080217, 00114471, 00568746, 00580569, 00697840, 00698064, 00746946, 01190445, 01604390, 01604409, 01607589, 02404256, 02428216, 02428222, 03907663, 03907692, 03907717, 04245112, 06180285, 06180291, 07276975, 08725122, 08725145, 10637632, 10868320
EE	Ravimiamet	1005107, 1005163, 1063077
ES	Centro de información online de medicamentos de la AEMPS	59069, 59070, 59071, 62944, 62945
FI	Lääkealan turvallisuus- ja kehittämiskeskus	153049, 406017, 406041, 520599
GB	Medicines & Healthcare Products Regulatory Agency	369095, 369097, 373523, 373655, 374188, 381775, 38288, 38292, 38784, 40630, 40645, 40652, 40664
HK	Department of Health Drug Office	33734, 33735, 33736, 45833, 45834
HR	Agencija za lijekove i medicinske proizvode	HR-H-774416957
IE	Health Products Regulatory Authority	53108, 53123, 53155, 53163, 53171, 53186, 53219, 53247, 53259, 53939, 53981, 53982, 73893
IL	מִשְׂרַד הַבְּרִיאוּת	2435, 2704, 311, 312
IT	Agenzia del Farmaco	027612011, 027612023, 027612098, 027612112
LT	Valstybinė vaistų kontrolės tarnyba	1002045, 1002048, 1004095, 1004096, 1005448, 1007842, 1032044, 1032045, 1032046, 1032047, 1032048, 1092161, 1092162
MT	Medicines Authority	AA565/07702
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	215M91, 216M91
NG	Registered Drug Product Database	04-3889
Switch country to Nigeria in order to find specific presentations of ZOFRAN
NL	Z-Index G-Standaard, PRK	44687, 46310, 49905, 49913
PL	Rejestru Produktów Leczniczych	100074679, 100074700, 100074716, 100082940, 100084146, 100103122, 100103139
SG	Health Sciences Authority	05133P, 05135P
TR	İlaç ve Tıbbi Cihaz Kurumu	8681428050703, 8681428050710, 8681428090686, 8681428090693, 8681428750894, 8681428750900
US	FDA, National Drug Code	0078-0675, 0078-0676, 80425-0072, 80425-0073, 80425-0075
ZA	Health Products Regulatory Authority	32/5.10/0461, 32/5.10/0462, X/5.10/331, X/5.10/332, X/5.10/333, Y/5.10/170